BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9123838)

  • 1. Protein composition and morphology of human foamy virus intracellular cores and extracellular particles.
    Morozov VA; Copeland TD; Nagashima K; Gonda MA; Oroszlan S
    Virology; 1997 Feb; 228(2):307-17. PubMed ID: 9123838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity.
    Zemba M; Wilk T; Rutten T; Wagner A; Flügel RM; Löchelt M
    Virology; 1998 Jul; 247(1):7-13. PubMed ID: 9683566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag.
    Tobaly-Tapiero J; Bittoun P; Giron ML; Neves M; Koken M; Saïb A; de Thé H
    J Virol; 2001 May; 75(9):4367-75. PubMed ID: 11287585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein.
    Löchelt M; Flügel RM
    J Virol; 1996 Feb; 70(2):1033-40. PubMed ID: 8551561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human foamy virus reverse transcriptase involves a spliced pol mRNA.
    Jordan I; Enssle J; Güttler E; Mauer B; Rethwilm A
    Virology; 1996 Oct; 224(1):314-9. PubMed ID: 8862427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses.
    Yu SF; Baldwin DN; Gwynn SR; Yendapalli S; Linial ML
    Science; 1996 Mar; 271(5255):1579-82. PubMed ID: 8599113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pol-related gene products of human foamy virus.
    Netzer KO; Schliephake A; Maurer B; Watanabe R; Aguzzi A; Rethwilm A
    Virology; 1993 Jan; 192(1):336-8. PubMed ID: 8390761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains.
    Kögel D; Aboud M; Flügel RM
    Virology; 1995 Oct; 213(1):97-108. PubMed ID: 7483284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression.
    Russell RA; Zeng Y; Erlwein O; Cullen BR; McClure MO
    J Virol; 2001 Aug; 75(15):6817-24. PubMed ID: 11435560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles.
    Baldwin DN; Linial ML
    J Virol; 1999 Aug; 73(8):6387-93. PubMed ID: 10400731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human foamy virus proteins expressed by recombinant vaccinia viruses.
    Fischer N; Enssle J; Müller J; Rethwilm A; Niewiesk S
    AIDS Res Hum Retroviruses; 1997 Apr; 13(6):517-21. PubMed ID: 9100994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the relative amounts of Gag and Pol proteins in foamy virus particles.
    Cartellieri M; Rudolph W; Herchenröder O; Lindemann D; Rethwilm A
    Retrovirology; 2005 Jul; 2():44. PubMed ID: 16004609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of higher primate foamy viruses, including a new virus from a gorilla.
    Bieniasz PD; Rethwilm A; Pitman R; Daniel MD; Chrystie I; McClure MO
    Virology; 1995 Feb; 207(1):217-28. PubMed ID: 7871729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of Pol and Env in the assembly pathway of human foamy virus.
    Baldwin DN; Linial ML
    J Virol; 1998 May; 72(5):3658-65. PubMed ID: 9557646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant HIV1 protease secreted by Saccharomyces cerevisiae correctly processes myristylated gag polyprotein.
    Pichuantes S; Babé LM; Barr PJ; Craik CS
    Proteins; 1989; 6(3):324-37. PubMed ID: 2695931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains.
    Yu SF; Edelmann K; Strong RK; Moebes A; Rethwilm A; Linial ML
    J Virol; 1996 Dec; 70(12):8255-62. PubMed ID: 8970944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.